"Studies Lend Credence To Click Therapeutics’ Digital Therapeutic For Depression" - Dave Muoio
The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). The studies showed the therapeutic to reduce symptoms, pair well with the transcranial direct-current simulation, and invoke a clear neurobiological mechanism related to cognitive control and emotional processing. “The data from these studies combined are incredibly encouraging for [Emotional Faces Memory Task (EFMT)] as an effective treatment for MDD,” said Brain Iacoviello, PhD, director of scientific affairs at Click Therapeutics and assistant professor of psychiatry at the Icahn School of Medicine at Mount Sinai. “Not only do we observe symptom improvement in adults with MDD, and adults with medication resistant depression when combined with tDCS, but for the first time we have shown that EFMT can have the neuroplastic effects expected in key brain regions involved in MDD, and that these changes are associated with symptom improvement.”
- Brian Iacoviello, PhD, Assistant Professor, Psychiatry, Icahn School of Medicine at Mount Sinai